This company seems to have been delisted
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Spectrum Pharmaceuticals
SPPI
S$1.33
Share price
0.00%
Change (1 day)
12.31%
Change (1 year)
Categories
Operating Margin for Spectrum Pharmaceuticals (SPPI)
Operating Margin as of July 2025 (TTM): -109.76%
According to Spectrum Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -109.76%. At the end of 2018 the company had an Operating Margin of -109.77%.
Operating Margin history for Spectrum Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2018 | -109.77% | 30.43% |
| 2017 | -84.15% | 74% |
| 2016 | -48.36% | 56.05% |
| 2015 | -30.99% | 33.01% |
| 2014 | -23.30% | -0.88% |
| 2013 | -23.51% | -179.68% |
| 2012 | 29.50% | 9.02% |
| 2011 | 27.06% | -141.03% |
| 2010 | -65.96% | 26.86% |
| 2009 | -51.99% | 3.22% |
| 2008 | -50.37% | -89.61% |
| 2007 | -484.81% | 6.22% |
| 2006 | -456.43% | -85.87% |
| 2005 | -3,231.02% | -34.87% |
| 2004 | -4,961.24% | 381.44% |
| 2003 | -1,030.50% | 69.03% |
| 2002 | -609.67% | -99.11% |
| 2001 | -68,469.52% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Teva Pharmaceutical Industries TEVA | -7.76% | -92.93% | 🇮🇱 Israel |
 Seagen
SGEN | -30.69% | -72.04% | 🇺🇸 USA |
 Curis CRIS | -397.77% | 262.40% | 🇺🇸 USA |
 Biogen BIIB | 17.85% | -116.26% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 12.82% | -111.68% | 🇺🇸 USA |
 Abbott Laboratories ABT | 17.36% | -115.82% | 🇺🇸 USA |
 Novartis NVS | 28.02% | -125.53% | 🇨🇭 Switzerland |
 Johnson & Johnson JNJ | 18.78% | -117.11% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | -111.48% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 13.32% | -112.14% | 🇬🇧 UK |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.